Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA™ (adalimumab-bwwd) in Multiple Presentations Consistent with OriginatorBusiness Wire • 07/01/23
Organon Publishes FY2022 ESG Report Showcasing Progress Toward Global Sustainability GoalsBusiness Wire • 06/27/23
Organon and CAF, Development Bank of Latin America, Launch First-of-Its-Kind Collaboration to Increase Sustainable Financing in Women's HealthBusiness Wire • 06/07/23
10 dividend stocks yielding at least 4.5% that are rated ‘buy' by most analystsMarket Watch • 04/17/23
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organon & Co. - OGNPRNewsWire • 03/13/23
Organon Launches “Her Plan is Her Power,” a New Global Initiative to Reduce Unplanned Pregnancies Where Need is Great and Disparities ExistBusiness Wire • 03/07/23